Information Provided By:
Fly News Breaks for February 8, 2016
STJ
Feb 8, 2016 | 07:26 EDT
Canaccord upgraded St. Jude Medical to Hold from Sell citing current valuation as they believe the shares are in a bottoming process. Canaccord maintained its $54 price target on St. Jude Medical shares.
News For STJ From the Last 2 Days
There are no results for your query STJ